| Revision as of 04:44, 2 March 2005 editCeyockey (talk | contribs)Administrators83,213 editsmNo edit summary← Previous edit | Revision as of 04:55, 25 March 2005 edit undo201.0.20.41 (talk)No edit summaryNext edit → | ||
| Line 9: | Line 9: | ||
| ] | ] | ||
| {{treatment-stub}} | {{treatment-stub}} | ||
| ] | |||
Revision as of 04:55, 25 March 2005
Duloxetine hydrochloride (brand name: Cymbalta) is a medically used drug that primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors.
Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.
External links
 | This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it. |